Matches in Nanopublications for { ?s ?p "[A phase I/II trial was undertaken to define the feasibility, safety and antitumor effects of the autologous vaccine prepared by transferring tag7/PGRP-S gene into malignant melanoma and renal cell carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP799137.RArZTjixquXrMOzdKkgMBcjj2SHq6KU9fIR-tQtth4vtk130_assertion description "[A phase I/II trial was undertaken to define the feasibility, safety and antitumor effects of the autologous vaccine prepared by transferring tag7/PGRP-S gene into malignant melanoma and renal cell carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP799137.RArZTjixquXrMOzdKkgMBcjj2SHq6KU9fIR-tQtth4vtk130_provenance.
- assertion description "[A phase I/II trial was undertaken to define the feasibility, safety and antitumor effects of the autologous vaccine prepared by transferring tag7/PGRP-S gene into malignant melanoma and renal cell carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A phase I/II trial was undertaken to define the feasibility, safety and antitumor effects of the autologous vaccine prepared by transferring tag7/PGRP-S gene into malignant melanoma and renal cell carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP472744.RAVwlF20-5k-UytTxzNbnh65JLR0f_zsy4MtrIo7D6CZg130_assertion description "[A phase I/II trial was undertaken to define the feasibility, safety and antitumor effects of the autologous vaccine prepared by transferring tag7/PGRP-S gene into malignant melanoma and renal cell carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472744.RAVwlF20-5k-UytTxzNbnh65JLR0f_zsy4MtrIo7D6CZg130_provenance.
- NP812589.RADjqnsppdpZTelBz8xyfJT2u0CJrDD8XT0rlxlO8-CaE130_assertion description "[A phase I/II trial was undertaken to define the feasibility, safety and antitumor effects of the autologous vaccine prepared by transferring tag7/PGRP-S gene into malignant melanoma and renal cell carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812589.RADjqnsppdpZTelBz8xyfJT2u0CJrDD8XT0rlxlO8-CaE130_provenance.
- NP812588.RAOMOYLfHH6go22_ZEQ3FLFMJfH9fnngg5OB9bUmsElNk130_assertion description "[A phase I/II trial was undertaken to define the feasibility, safety and antitumor effects of the autologous vaccine prepared by transferring tag7/PGRP-S gene into malignant melanoma and renal cell carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812588.RAOMOYLfHH6go22_ZEQ3FLFMJfH9fnngg5OB9bUmsElNk130_provenance.
- NP472746.RA3rKh64Jgw45uVWLErxuZh5X1VtYS9pXm7B47FLR9yew130_assertion description "[A phase I/II trial was undertaken to define the feasibility, safety and antitumor effects of the autologous vaccine prepared by transferring tag7/PGRP-S gene into malignant melanoma and renal cell carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472746.RA3rKh64Jgw45uVWLErxuZh5X1VtYS9pXm7B47FLR9yew130_provenance.